Cardiology
Conference Coverage
Vitamin D, fish oil circling the drain for primary prevention
CHICAGO – Massive VITAL trial shows the popular supplements don’t lower cardiovascular or cancer risk.
News
New cholesterol guidelines expand options for primary care
Conference Coverage
DECLARE: Dapagliflozin improves some cardiovascular, renal outcomes
The large outcomes trial didn’t show a benefit in major adverse cardiovascular events.
Conference Coverage
REDUCE-IT: Fish-derived agent cut CV events 25%
Vascepa plus statin reduced the risk of cardiovascular death or nonfatal MI and stroke by 25%.
Feature
Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ report
The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.
Conference Coverage
Quality tool tied to improved adherence
CHICAGO –
From the Journals
Lower glucose targets show improved mortality in cardiac patients
Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.
From the Journals
ICYMI: Alirocumab improves cardiovascular outcomes
Conference Coverage
AHA promises practice-changing late breakers
.
Guidelines
Bradycardia guideline sets new bar for shared decision-making in pacemaker placement
Patients with decision-making capacity or their legally defined surrogates have the right to refuse or request withdrawal of pacemaker therapy.
Conference Coverage
New cholesterol, physical activity guidelines on tap at AHA 2018
Controversial cholesterol guidelines undergo major revision.